ATAI Life Sciences NV Net Asset Momentum
ATAI Life Sciences NV net asset momentum. ATAI Life Sciences NV (9VC) recorded a net asset momentum of -52.3% as of December 2024, with net assets of €116.55 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore ATAI Life Sciences NV (9VC) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ATAI Life Sciences NV (2019–2024)
Net asset momentum of ATAI Life Sciences NV from 2019 to 2024. This chart tracks ATAI Life Sciences NV's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -52.3%, with net assets of €116.55 Million EUR as of December 2024. See what is ATAI Life Sciences NV's book value for net asset value and shareholders' equity analysis.
ATAI Life Sciences NV Net Asset Momentum by Year (2019–2024)
ATAI Life Sciences NV net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for ATAI Life Sciences NV from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of ATAI Life Sciences NV.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €116.55 Million | €159.39 Million | €42.83 Million | ▼ -52.3% |
| 2023 | €244.32 Million | €293.48 Million | €49.16 Million | ▼ -8.1% |
| 2022 | €265.77 Million | €305.44 Million | €39.67 Million | ▼ -31.1% |
| 2021 | €385.96 Million | €414.17 Million | €28.21 Million | ▲ +304.7% |
| 2020 | €95.37 Million | €111.55 Million | €16.18 Million | ▲ +59.9% |
| 2019 | €59.64 Million | €62.12 Million | €2.48 Million | — |